Bulk Inquiry
SMT C1100
- Ezutromid - BMN-195
- Soluble in DMSO
- MF: C19H15NO3S
- MW: 337.39
Description
Orally active, non-toxic upregulator of utrophin production (EC50 value 0.91 µM in a utrophin A promoter H2K cell-based assay with a luciferase reporter readout) for the treatment of Duchenne muscular dystrophy (DMD). What's more, SMT C1100 significantly reduces dystrophin-deficient muscle pathology in vivo.
More Information
| Parent CAS No. | 945531-77-1 |
|---|---|
| Chemical Name | 5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole |
| SMILES | O1C2=CC=C(S(=O)(=O)CC)C=C2N=C1C1=CC=C2C(=C1)C=CC=C2 |
| MFCD | N.A. |
| InChi | InChI=1S/C19H15NO3S/c1-2-24(21,22)16-9-10-18-17(12-16)20-19(23-18)15-8-7-13-5-3-4-6-14(13)11-15/h3-12H,2H2,1H3 |
| InChiKey | KSGCNXAZROJSNW-UHFFFAOYSA-N |
| CID | 25109292 |
| Short Description | Utrophin upregulator |
References
- J.M. Tinsley et al. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLoS One. 2011 May 6;6(5):e19189.
- D.R. Chancellor et al. Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy. J Med Chem. 2011 May 12;54(9):3241-50.
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1442 | Caprospinol |
From $121.00 |
| 1766 | ICG 001 |
From $126.50 |
| 2084 | SKL 2001 |
From $99.00 |
| 2120 | Wnt agonist 1 |
From $99.00 |
| 2133 | iCRT5 |
From $99.00 |
| 2135 | iCRT14 |
From $143.00 |
| 2161 | CCT 031374 hydrobromide |
From $66.00 |
| 2378 | Kartogenin |
From $82.50 |
| 3715 | E-7386 |
From $275.00 |
Other Categories
Are you sure you would like to remove this item from the shopping cart?
This item is a part of the approved quote. Removing it will remove all quote items from the cart.